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Summary
 
Rearranged immunoglobulin variable genes are extensively mutated after stimulation of B lym-
phocytes by antigen. Mutations are likely generated by an error-prone DNA polymerase, and
the mismatch repair pathway may process the mispairs. To examine the role of the MSH2 mis-
match repair protein in hypermutation, 
 
Msh2
 
2
 
/
 
2
 
 mice were immunized with oxazolone, and B
cells were analyzed for mutation in their V
 
k
 
Ox1 light chain genes. The frequency of mutation
in the repair-deficient mice was similar to that in 
 
Msh2
 
1
 
/
 
1
 
 mice, showing that MSH2-depen-
dent mismatch repair does not cause hypermutation. However, there was a striking bias for
mutations to occur at germline G and C nucleotides. The results suggest that the hypermuta-
tion pathway frequently mutates G
 
?
 
C pairs, and a MSH2-dependent pathway preferentially
corrects mismatches at G and C.
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H
 
ypermutation of immunoglobulin variable (V) genes
occurs in B lymphocytes after antigen stimulation.
Mutations are generated 1,000,000 times more frequently
in V genes than in other genes, which implies that the
mechanism that causes hypermutation is different than
those that generate spontaneous mutations. Furthermore,
the hypermutation mechanism is unique because it intro-
duces mutations into a small area on three chromosomes
that contain rearranged V, diversity, and joining (J) gene
segments for heavy, 
 
k
 
, and 
 
l
 
 immunoglobulin chains (for
review see reference 1). A survey of the substitutions shows
that transitions are found twice as frequently as transver-
sions; germline G, A, and C nucleotides on the coding
strand have an equal frequency of undergoing mutation,
and T is mutated less frequently (2). Once mutations occur
on the DNA strands, they would typically be substrates for
the mismatch repair pathway.
During semiconservative replication, mismatched base
pairs are recognized and corrected by several repair pro-
teins. These proteins, MutS homologue 2 (MSH2)
 
1
 
, MSH3,
MSH6, post-meiotic segregation 2 (PMS2), and Mut L ho-
molog 1 (MLH1), form a multiprotein complex that recog-
nizes and excises mismatch errors (for review see reference
3). Once excised, DNA polymerases 
 
d
 
 or 
 
e
 
 resynthesize the
repair gap. There are several ways in which the mismatch
repair pathway could be involved in somatic hypermuta-
tion: (
 
a
 
) mismatch repair may actually cause the mutations
by processing heteroduplex secondary structures that could
form in the V region (4), (
 
b
 
) during occasional repair of
DNA damage, an error-prone DNA polymerase might in-
troduce mismatches in the repair gap (5, 6); or (
 
c
 
) mismatch
repair might be actively suppressed in the V region, allow-
ing normal replicative mismatch errors to accumulate. In
any of these cases, mismatch repair may exhibit a prefer-
ence for removing particular mismatches. 
We analyzed the frequency and pattern of mutation in V
genes from mice deficient for the MSH2 protein because
this protein is a critical component of repair complexes that
initially bind DNA mismatches. MSH2-deficient mice
demonstrate a lack of mismatch repair in that they have un-
stable microsatellite repetitive sequences in transformed
cells, and they have a high incidence of lymphoid tumors
(7–9). MSH2-deficient cells from mice or humans are also
defective in repairing single-base mismatches (10) and have
 
1
 
Abbreviations used in this paper:
 
 MLH, Mut L homologue; MSH, Mut S
homologue; 
 
Pfu
 
, Pyrococcus furiosus; PMS, post-meiotic segregation;
V
 
k
 
Ox1, V gene for the 
 
k
 
 chain that binds to oxazolone.
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elevated mutation rates (11–13). Overall, the immune sys-
tem of 
 
Msh2
 
2
 
/
 
2
 
 mice appears to be relatively normal in
that the composition of T and B cells is similar to 
 
Msh2
 
1
 
/
 
1
 
mice (8). Thus, these mice should respond to antigen, and
it will be possible to see what the pattern of hypermutation
looks like before MSH2-dependent repair processes the
mutations.
 
Materials and Methods
 
Mice.
 
MSH2-deficient mice were generated by an insertion
of a neomycin-resistance (
 
neo
 
) gene into one of the exons encod-
ing MSH2 (8). Mice heterozygous for the 
 
Msh2
 
 gene on a mixed
C57BL/6 and 129/Ola background were mated to produce F1
progeny. The mice were genotyped using a PCR-specific assay
on DNA from ear notches. Two 8-wk-old 
 
Msh2
 
2
 
/
 
2
 
 mice were
immunized intraperitoneally with 100 
 
m
 
g of phenyl-oxazolone
coupled to chicken serum albumin (provided by M. Neuberger,
Cambridge, UK) in adjuvant (RIBI ImmunoChem Research,
Inc., Hamilton, MT). 4 wk later, the mice were given a second-
ary injection of 40 
 
m
 
g of antigen in adjuvant. 4 d later, the mice
were killed and the spleens removed. Some 5% of splenic B cells
that bound the B220 surface marker and peanut agglutinin (PNA)
were sorted by flow cytometry using a FACStar Plus
 
Ò
 
 (Becton
Dickinson, San Jose, CA). Approximately 100 ng of DNA was
isolated from about 50,000 cells after proteinase K digestion and
phenol/chloroform extraction.
 
Detection of Neo Insert.
 
To confirm that the mice used in this
study contained the 
 
neo
 
 insert on both alleles, splenic DNA from
the same B220
 
1
 
PNA
 
1
 
 B cells that were analyzed for mutation
was amplified by PCR using primer sequences obtained from
Tak Mak (Amgen Institute, Toronto, Canada). To detect the
wild-type exon, primers specific for the 5
 
9
 
 intron and 
 
Msh2
 
 exon
were used, which would generate a 174-bp fragment: 5
 
9
 
 primer
U771, 5
 
9
 
GCTCACTTAGACGCCATTGT3
 
9
 
, and 3
 
9
 
 primer
L926, 5
 
9
 
AAAGTGCACGTCATTTGGA3
 
9
 
. To detect the 
 
neo
 
insert, primers specific for the 5
 
9
 
 intron and the 
 
neo
 
 gene were
used, which would generate a 460-bp product: 5
 
9
 
 primer U771 as
above, and 3
 
9
 
 primer L1211, 5
 
9
 
GCCTTCTTGACGAGT-
TCTTC3
 
9
 
. A heterozygous mouse would produce both frag-
ments. 10 ng of DNA from B220
 
1
 
PNA
 
1
 
 spleen cells from
C57BL/6 mice or 
 
Msh2
 
2
 
/
 
2
 
 mice was amplified for 40 cycles and
the products were detected by gel electrophoresis. As shown in
Fig. 1, C57Bl/6 DNA contained the wild-type 
 
Msh2
 
 gene, and
the 
 
Msh2
 
2
 
/
 
2
 
 DNA had the correct size for a 
 
neo
 
 insertion into the
 
Msh2
 
 gene.
 
V Gene Cloning and Sequencing.
 
The rearranged V gene for
the 
 
k
 
 light chain that binds to oxazolone (V
 
k
 
Ox1) gene was am-
plified from 20 ng of DNA by 30 rounds of PCR with 
 
Pyrococcus
furiosus
 
 (
 
Pfu
 
) polymerase (Stratagene, La Jolla, CA) using a primer
specific for the leader sequence on the 5
 
9
 
 side of the gene and a
primer specific for the J
 
k
 
5 gene segment on the 3
 
9
 
 side. 1/25 of
the reaction was then amplified for another 30 rounds using
nested primers containing restriction sites. The 487-bp product,
which included 5
 
9
 
 intron and V-J exon sequences, was cloned
into M13 bacteriophage, and DNA from plaques was sequenced.
The error-rate for 
 
Pfu
 
 polymerase under these conditions is 8 
 
3
 
10
 
2
 
7
 
 mutations/bp/duplication (14; Gearhart, P.J., data not
shown); after 60 rounds of amplification of a 487-bp fragment,
the cumulative error rate is 200-fold less than the number of mu-
tations detected in the V
 
k
 
Ox1 gene.
 
Statistical Analysis.
 
A statistical test of whether the mutation
frequency in A
 
?
 
T pairs is equal to the mutation frequency in G
 
?
 
C
pairs was based on the ratio of the number of mutations in A
 
?
 
T
pairs to the number of mutations in G
 
?
 
C pairs. The level of sig-
nificance was determined using exact Poisson calculations (15),
with correction for the unequal base composition in the region
studied, where there are 263 A
 
?
 
T pairs and 203 G
 
?
 
C pairs.
 
Results
 
MSH2-Deficient Mice Have Hypermutated Antibodies.
 
We
studied mutation in the rearranged V
 
k
 
Ox1 gene segment
because immunization of mice with oxazolone elicits a
well-characterized antibody response (16). Some 38 clones
were sequenced over a length of 487 bp, which included
190 nucleotides of 5
 
9
 
 intron sequence between the leader
and V gene segment, and 297 nucleotides of the V-J gene.
Sequences at the V-J junction were used to establish clonal
identity, but were not included in the mutational analysis
because variant nucleotides at the site of joining may be in-
troduced by the recombination mechanism rather than by
the hypermutation pathway. Thus, mutations were re-
corded for 466 nucleotides starting downstream of the
leader sequence in the 5
 
9
 
 intron and ending in the V gene
before the J gene segment. 44 out of 60 
 
Msh2
 
2
 
/
 
2
 
 clones
had mutation, or 73%, compared to 49 out of 82 
 
Msh2
 
1
 
/
 
1
 
clones with mutation, or 60%. To calculate the frequency
of mutation, we only considered the mutated clones. This
ensures that the analysis is performed on clones from B cells
that have been activated to mutate, rather than including
nonmutated clones from B cells that may not have been
stimulated. 22 of the mutated 
 
Msh2
 
2
 
/
 
2
 
 clones were unique
in that they either had different sequences at the V-J junc-
tion, indicating they came from independent precursor B
cells, or they had unique single substitutions that were not
shared by other clones. As listed in Table 1, the number of
Figure 1. Detection of a neo insert in the Msh2 gene in B2201PNA1
splenic B cells from Msh22/2 mice. PCR products were electrophoresed
through an agarose gel and stained with ethidium bromide. Lane 1, 100-
bp ladder; lanes 2–5, amplification of DNA with primers as noted.1747 Phung et al.
mutations per Msh22/2 clone ranged from 1 to 14, with an
average frequency of 1.3% mutations/bp. This frequency is
very similar to that found in Msh21/1 C57BL/6 clones for
the VkOx1 gene, where the number of mutations per clone
ranged from 1 to 17, with an average frequency of 1.4%
mutations/bp (18). All 135 mutations in Table 1 were nu-
cleotide substitutions, and only three were located in the 59
intron. Three pairs of tandem mutations, or two substitu-
tions in a row, were observed.
To determine if the pattern of mutation differs between
Msh22/2 clones and Msh21/1 C57BL/6 clones, the posi-
tion and types of mutations were identified. As shown in
Fig. 2, many of the mutations in both strains of mice were
located in the first complementarity-determining region at
amino acid codons 34 and 36 (nucleotides [nt] 97–99 and
103–105). Mutations at these residues have been shown to
increase the affinity of antibodies by 10-fold (20) because
these sites directly interact with the oxazolone molecule
(21). Thus, B cells expressing antibodies with mutations in
codons 34 and 36 are highly selected based on their greater
affinity for antigen than nonmutated antibodies. Compar-
ing the patterns, several hypermutable sites were observed
in Msh22/2 clones but not in Msh21/1,C57BL/6 clones: nt
96 (codon 33), which is not located in the RGYW motif
that is suggested to be a preferential sequence for mutation
(22), and nt 227 (codon 77), which is in an RGYW se-
quence.
Msh22/2 Clones Have Predominantly Mutations at G and C
Nucleotides. The data in Fig. 2 demonstrate that most of
the mutations in the Msh22/2 clones are substitutions for
germline G or C. An analysis of the nucleotide changes for
each base is summarized in Table 2. For comparison, data
from identical mutational analyses of VkOx1 genes (18)
from another mismatch repair–deficient strain, Pms22/2, a
nucleotide excision repair–deficient strain, xeroderma pig-
mentosum group A (Xpa2/2), and the C57BL/6 strain are
also included. In the Msh22/2 sequences, very few muta-
tions at germline A and T and a much greater proportion
of mutations at germline G and C were observed in com-
parison to the other three strains. Msh22/2 clones exhibited
only nine mutations at A and T versus 91 mutations at G
and C, whereas clones derived from the other strains had
Table 1. Mutations in VkOx1 Genes from MSH2-deficient Mice
Clone Number Position*
M42 1 C30T
M70 1 G160A
M5 2 G37T, C97A
M53 4 G25C, C97A, A104T, G227A
M128 5 G37A, C78T, C97A, A104T, G227A
M89 5 G25A, C78T, C97A, A104T, G227A
M34 5 G77A, A87T, G89C, C97A, C261T
M71 5 G25A, G96A, C99G, A104T, G119C
M95 6 G227A, G235A, G264A, G267A, G269A, G270T
M106 6 T-129A, G166A, C176T, G195A, A226C, C228A
M85 7 G71C, G73C, C78T, G96A, C99G, A104T, G227A
M11 7 C20A, G71T, C99G, C122T, C126A, G175A, G227A
M23 7 G25A, G96A, C99G, A104T, G166A, C176T, G227C
M10 7 G-79T, C78G, C99G, A104T, G119C, C225T, G227A
M36 7 G-125A, C-122T, G25A, G96A, C99G, A104T, G119C
M115 7 C41T, C43T, C69T, C97A, G166A, C176T, G227C
M117 7 C60A, C66T, T72G, G96A, T115C, C120A, A121T
M120 7 G71A, G73A, G77A, G83A, G89A, C105T, C204T
M101 8 C41T, C43T, G96A, C99A, C105T, G166A, G224A, C228T
M119 8 G68A, G77C, C99G, A104T, G108A, A207T, G224A, G207A
M64 9 C78T, G83C, G96A, C120T, C123T, C125T, G175A, G224A, G227A
M82 14 G71C, G73C, C78T, C80T, G96A, C99G, A104T, C123T, C126T, A133T, G134T, A217T, G224A, G227A
Total 5 22 clones (10,252 bp); 135 mutations; 1.3% mutations/bp.
*Mutations are listed with the first letter representing the germline nucleotide, the number depicting the position of the mutation as shown in Fig. 2,
and the second letter signifying the mutant nucleotide. Negative numbers correspond to mutations in the 59 intron (17). Tandem mutations are un-
derlined.1748 Bias for Hypermutation at G?C Pairs in MSH2-deficient Mice
approximately the same number of mutations at A?T and
G?C pairs. When corrected for nucleotide composition, a
ratio of 1.3:1 mutations at A?T to G?C pairs would be ex-
pected if the mutation rates at both pairs were equal. As
shown in Fig. 3, P values for whether the ratio was 1.3:1
were ,1026 for Msh22/2 clones, 0.21 for Pms22/2 clones,
0.20 for Xpa2/2 clones, and 0.90 for C57BL/6 clones.
Thus, hypermutation of the VkOx1 gene in Msh22/2 mice
is vastly skewed towards targeting G?C pairs compared to
the other strains.
Discussion
Msh22/2 mice do not appear to be immunodeficient for
hypermutation by the following criteria. First, these mice
possess the same percentage of PNA1 B cells as Msh21/1
mice, suggesting that the B cells passaged through germinal
centers (23). Second, the frequency of mutation between
Msh22/2 and Msh21/1 C57BL/6 clones was identical, indi-
cating that there was active hypermutation at the VkOx1
locus. Third, B cells in both strains of mice underwent af-
finity maturation as codons 34 and 36 were selected for the
mutations that produce high affinity antibodies to ox-
azolone (20, 21). It is quite possible that Msh22/2 mice
have other immune defects; for example, they may have
fewer germinal centers. However, it has been shown that
hypermutation and affinity maturation can proceed in the
absence of germinal centers (24).
Unexpectedly, the frequency of mutation was not higher
in Vk genes from MSH2-deficient mice compared to wild-
type mice. Jacobs et al. (25) also reported a normal fre-
quency of mutation in the Vl1 gene from Msh22/2 mice.
Perhaps the hypermutation frequency in V genes is already
so high at 1022 mutations/bp that the molecule cannot tol-
erate higher loads of mutation because the antibody protein
will be nonfunctional. Since MSH2 is necessary for canon-
ical mismatch repair, the data strongly suggest that this re-
pair pathway is not required to generate somatic hypermu-
tation in V genes. We observed a high level of mutation
(0.9% mutations/bp) in the VkOx1 gene from mice defi-
Figure 2. Location of muta-
tions in the VkOx1 gene from
Msh21/1 C57BL/6 and Msh22/2
mice. The coding region of the
VkOx1 gene segment is shown;
nucleotide and codon number-
ing is according to Kabat et al.
(19). The 276-bp coding region
contained 90% of all mutations
occurring in the entire 466-bp
sequence.  Msh21/1 C57BL/6
substitutions (18) are displayed
above the coding sequence and
Msh22/2 substitutions are
shown below. Codons 34 (nt
97–99) and 36 (nt 103–105) are
underlined.
Table 2. Pattern of Substitutions in VkOx1 Genes from DNA 
Repair–deficient Mice
Substitution
Msh22/2 Pms22/2 Xpa2/2 C57BL/6
% (No.) % (No.) % (No.) % (No.)
A to G 0 (0) 17 (13) 19 (23) 19 (17)
A to T 5 (5) 8  (6) 8 (10) 16 (15)
A to C 1 (1) 8 (6) 6 (7) 11 (10)
T to C 1 (1) 7 (5) 8 (10) 9 (8)
T to A 1 (1) 4 (3) 7 (9) 2 (2)
T to G 1 (1) 5 (4) 2 (2) 1 (1)
C to T 25 (27) 12 (9) 17 (21) 10 (9)
C to A 5 (5) 3 (2) 3 (4) 2 (2)
C to G 1 (1) 9 (7) 2 (2) 2 (2)
G to A 44 (48) 19 (15) 19 (24) 17 (16)
G to T 5 (5) 1 (1) 3 (4) 4 (4)
G to C 11 (13) 7 (5) 6 (7) 7 (6)
Mutations in the 59 flanking and VkOx1 coding region are listed. Mu-
tations in codons 34 and 36 were excluded because of strong immuno-
logical selection for these mutations. Data for Pms22/2, Xpa2/2, and
C57BL/6 clones (18) were generated the same way as in this Msh22/2
study.1749 Phung et al.
cient for another mismatch repair protein, PMS2 (18), fur-
ther confirming that mismatch repair does not generate
mutations in immunoglobulin genes. On the other hand,
Cascalho et al. (26) reported a decreased frequency of mu-
tation in Pms22/2 quasimonoclonal mice and suggested that
mismatch repair is involved in fixing mutation once it is
generated. Since many factors can influence the frequency
of mutation, such as quality of antigen stimulation, rate of
transcription (27), and germinal center formation (24), de-
creased frequencies should be interpreted with caution.
Furthermore, localized inactivation of the mismatch re-
pair pathway is not solely responsible for permitting large
numbers of mutations to remain around the rearranged V
gene. Indeed, an active mechanism for increasing the base
substitution frequency must be used to generate the ob-
served frequency of 1022 mutations/bp. Simple inactiva-
tion of mismatch repair may reveal frequent insertions and
deletions of nucleotides that are produced by slippage of
DNA polymerase during normal semiconservative DNA
replication (8, 28). Insertions and deletions would be most
evident in the noncoding flanking sequences where they
would not cause a frameshift. In this study, there were no
insertions or deletions in the 59 flanking or coding regions
of V genes from Msh22/2 mice. However, occasional in-
sertions and deletions that are templated by adjacent nucle-
otides have been identified in a recent study (29), which
suggests that slippage of DNA polymerase occurs infre-
quently.
Tandem mutations of two in a row were observed at a
high frequency in another mismatch repair–deficient strain
lacking PMS2 (18), suggesting that the PMS2 component
of the mismatch repair pathway is involved in repairing
doublet mutations. To determine if the MSH2 protein is
also used to repair tandem mutations, we analyzed the mu-
tational pattern. Three tandem mutations in Msh22/2
clones were observed (Table 1) compared to 1.8 expected
by chance, and exact Poisson calculations indicate no sig-
nificant excess of tandem mutations (P 5 0.56). In contrast,
there were 11 tandem mutations observed in Pms22/2
clones compared to only 1.2 expected (P , 1026). Thus,
repair of tandem mutations introduced by the hypermuta-
tion mechanism is dependent on PMS2, but appears largely
independent of MSH2, suggesting a pathway for repair of
certain mismatches that does not involve all the canonical
components of mismatch repair.
MSH2 appears to play a dominant role in modifying the
spectrum of mutations formed during hypermutation. A
very different mutational pattern was seen in the Msh22/2
clones, with the vast majority of mutations occurring at
germline G and C nucleotides compared to A and T nucle-
otides (P , 1026). We noticed that data from Jacobs et al.
(25) had a similar bias for mutation at G?C pairs in rear-
ranged Vl genes from an independently derived MSH2-
deficient mouse (7). Our calculations of P values for their
data showed that Msh22/2 clones had a significant excess of
mutations at G?C pairs (P 5 0.001) unlike clones from
wild-type and other DNA repair–deficient mice in their
study (P . 0.4). Although the effect of driving mutation at
G?C pairs produced new hot spots of mutation with corre-
sponding amino acid changes in the VkOx1 gene (Fig. 2),
the G?C bias did not affect selection for high affinity anti-
bodies. Thus, infrequent mutations of A at nt 104 in codon
36 were strongly selected because they change the tyrosine
codon to phenylalanine, which confers a 10-fold increase
in affinity on the antibody molecule (20, 21).
The skewed mutational pattern in Msh22/2 clones pre-
dicts that during hypermutation, either G or C are chemi-
cally modified to cause mispairing, or an error-prone poly-
merase frequently introduces a wrong base opposite these
nucleotides. For convention, all the mutations in Table 2
were recorded from the coding strand, although it is not
known on which strand mutations actually occur. Chemi-
cal modifications of G and C can occur by several methods.
First, G can be oxidized to 8-oxyguanine (30) that, if not
removed by the base excision repair pathway, preferentially
pairs with A to cause a G to T transversion on one strand
or the corresponding C to A transversion on the opposite
strand. Germinal centers express a high level of 8-oxogua-
nine glycosylase (31), suggesting there is a high level of ox-
ygen radicals in this tissue. However, this cannot be a ma-
jor mechanism of somatic hypermutation in V genes since
G to T and C to A changes only account for 1–5% of the
substitutions in all four strains of mice shown in Table 2.
Second, 5-methyl C in a CpG motif can undergo deamina-
tion to produce the C to T transition (32). However, none
of the mutations occurred at CpG dinucleotides. Third, C
could spontaneously deaminate to produce uracil, leading to
a C to T transition (33), or C could be oxidized to 5-hydroxy
cytidine (34), but these damaged bases are usually removed
Figure 3. Bias for mutations at G?C pairs in Msh22/2 clones. Frequen-
cies of mutation of germline nucleotide pairs to any other base were calcu-
lated after correction for base composition. P values for whether the mu-
tation frequency in A?T pairs is equal to the mutation frequency in G?C
pairs are shown.1750 Bias for Hypermutation at G?C Pairs in MSH2-deficient Mice
by uracil-DNA glycosylase and endonuclease III type en-
zymes. It is possible that some of these enzymes are defi-
cient in germinal centers from Msh22/2 mice, which could
produce the altered pattern. Alternatively, an error-prone
polymerase could frequently introduce a wrong base oppo-
site G or C. One of the known DNA polymerases may be
modified to become more error prone (for review see ref-
erence 35), or a novel polymerase may be expressed in ger-
minal centers to generate the high frequency of substitu-
tions.
Concomitantly, the data predict that MSH2 preferen-
tially corrects mismatches of G or C relative to mismatches
of A or T. For example, if a DNA polymerase puts T op-
posite a germline G, the G?T mismatch will be recognized
by a heterodimer of MSH2 and MSH6 proteins (36, 37). In
the absence of MSH2, G?T mispairs would remain and
produce an increased frequency of G to A mutations. In
the presence of MSH2, the disproportionate number of
mismatches at G or C would be corrected, and the final
frequency of mutation at germline-encoded G?C and A?T
pairs would be equal. MSH2-dependent repair of G and C
mismatches in V genes appears to be independent of
PMS2, since a G?C bias was not observed in Pms22/2
clones. As MSH2 normally forms a heterodimer with the
MSH6 or MSH3 proteins during conventional mismatch
repair (38), it will be interesting to determine the pheno-
type of mutation in mice deficient for the latter two pro-
teins.
A bias for mutations at G?C pairs has been reported in
IgM molecules from Xenopus and horned shark (39–41),
raising the possibility that this phenotype indicates low or
absent levels of the MSH2 protein in some cold blooded
vertebrates. Mismatch repair has not been studied in these
species, and it would be interesting to see if they are defi-
cient in repair of G and C mismatches. A bias for mutations
at G and C bases was also noted in a murine pre–B cell line
(42). Similarly, humans with defective Msh2 genes, as iden-
tified by susceptibilty to colorectal and other cancers (43),
may have altered patterns of hypermutation that affect the
ability of their antibodies to bind antigen efficiently.
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